RetinalGenix Technologies Inc.
RTGN · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.90 | -3.03 | 1.15 | -0.24 |
| FCF Yield | -0.16% | -0.15% | -0.20% | -0.65% |
| EV / EBITDA | 0.00 | -142.13 | -158.85 | -33.24 |
| Quality | ||||
| ROIC | 0.00% | 33.68% | 36.38% | 68.95% |
| Gross Margin | 0.00% | 0.00% | 0.00% | -879.00% |
| Cash Conversion Ratio | 0.18 | 0.21 | 0.32 | 0.21 |
| Growth | ||||
| Revenue 3-Year CAGR | 46,315.89% | 46,315.89% | 46,315.89% | 46,315.89% |
| Free Cash Flow Growth | 25.34% | 25.72% | -0.45% | 24.52% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -0.09 | -0.09 | -0.06 |
| Interest Coverage | 0.00 | -605.93 | -645.05 | -902.15 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -136,366.10 | -124,775.68 | -94,411.23 |